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Abstract
Intestinal epithelial dysplasia (IED), also known as tufting enteropathy, is a congenital enteropathy
presenting with early-onset severe intractable diarrhea causing sometimes irreversible intestinal
failure. To date, no epidemiological data are available, however, the prevalence can be estimated at
around 1/50,000–100,000 live births in Western Europe. The prevalence seems higher in areas with
high degree of consanguinity and in patients of Arabic origin. Infants develop within the first days
after birth a watery diarrhea persistent in spite of bowel rest and parenteral nutrition. Some infants
are reported to have associated choanal rectal or esophageal atresia. IED is thought to be related
to abnormal enterocytes development and/or differentiation. Nonspecific punctuated keratitis was
reported in more than 60% of patients. Histology shows various degree of villous atrophy, with low
or without mononuclear cell infiltration of the lamina propria but specific histological abnormalities
involving the epithelium with disorganization of surface enterocytes with focal crowding,
resembling tufts. Several associated specific features were reported, including abnormal deposition
of laminin and heparan sulfate proteoglycan (HSPG) in the basement membrane, increased
expression of desmoglein and ultrastructural changes in the desmosomes, and abnormal
distribution of α2β1 integrin adhesion molecules. One model of transgenic mice in which the gene
encoding the transcription factor Elf3 is disrupted have morphologic features resembling IED.
Parental consanguinity and/or affected siblings suggest an autosomal recessive transmission but the
causative gene(s) have not been yet identified making prenatal diagnosis unavailable. Some infants
have a milder phenotype than others but in most patients, the severity of the intestinal
malabsorption even with enteral feeding make them totally dependent on daily long-term
parenteral nutrition with a subsequent risk of complications. IED becomes an indication for
intestinal transplantation, while timing of referral for it is crucial before the onset of severe
complications.
Disease name and synonyms
Intestinal epithelial dysplasia
Tufting enteropathy
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Congenital enteropathy
Congenital familial intractable diarrhea with enterocytes
assembly abnormalities
Definition
Intestinal epithelial dysplasia (IED), also known as tufting
enteropathy, is a congenital enteropathy presenting with
early-onset severe intractable diarrhea and persistent vil-
lous atrophy with low or without mononuclear cell infil-
tration of the lamina propria but specific histological
abnormalities involving the epithelium [1,2]. IED is char-
acterized by clinical and histological heterogeneity and
association with malformations or other epithelial dis-
eases. It is thought to be related to abnormal enterocytes
development and/or differentiation.
Epidemiology
IED appears to be more common than microvillous atro-
phy (MVA), also known as microvillous inclusion disease
(MVID), especially in Middle-East, however, it remains
very rare. Many cases are not yet recognized since the
description of this disorder is recent. To date, no epidemi-
ological data are available, however, the prevalence can be
estimated at around 1/50,000–100,000 live births in
Western Europe. The largest cohort of patients is currently
being treated at the Necker-Enfants Malades Hospital in
Paris, France. The prevalence is higher in countries with
high degree of consanguinity. Our studies indicate that
IED is frequent in patients of Arabic origin (Middle-East,
Turkey and North Africa). The prevalence is also high in
the island of Malta (in the Mediterranean sea) but the
phenotype appears to be milder.
History of the description
IDE is a newly described clinicopathologic entity with
intractable diarrhea in infants. Three cases of neonatal
severe diarrhea with abnormal epithelial pictures were
first reported by Reifen et al., 1994, under the name of
'tufting enteropathy" [3]. We identified nine cases of
severe neonatal diarrhea, which were clearly distinguisha-
ble from MVA and resembled "tufting enteropathy" [4].
Further studies of these patients allowed us to identify IED
as a constitutive epithelial disorder involving both small
intestine and colon [5]. A main characteristic of this dis-
ease is its clinical and histological heterogeneity and its
association with malformations or other epithelial dis-
eases.
Clinical description, associated disorders and 
diagnostic criteria
In general, infants with IDE develop watery diarrhea
within the first days after birth. It is severe in most of the
cases. Stool volumes may be as high as 100–200 ml/kg
body weight per day, with electrolyte concentrations sim-
ilar to those seen in small intestinal fluid. In rare cases the
diarrhea may be less abundant and sometimes may mis-
lead the diagnosis [5]. The growth is impaired. There is no
past history of hydramnios suggesting congenital chloride
diarrhea or sodium malabsorption diarrhea. Most
patients have consanguineous parents and/or affected sib-
lings, some of whom died during the first months of life
from severe diarrhea of unknown origin.
Several cases of IED have been reported as being associ-
ated with phenotypic abnormalities, for example Dubow-
itz syndrome or malformative syndrome [6-8]. Some
affected children are reported to have dysmorphic facial
features [6]. An association between congenital intracta-
ble diarrhea of infancy (IDI) and choanal atresia has been
reported in four children [7]. We have observed malfor-
mations, including esophageal atresia, choanal atresia, or
unperforated anus. Moreover, nonspecific punctuated
keratitis is observed in more than 60% of patients [8]. This
associated keratitis is very intriguing since it is also an epi-
thelial disease and therefore studies of keratitis might help
to elucidate the molecular mechanisms of the intestinal
epithelial disease. The fact that some children have oph-
thalmological symptoms and keratitis highlights the het-
erogeneity of IED (Salomon et al., manuscript in
preparation).
Histological presentation
Histological abnormalities in IED include villous atrophy,
disorganization of the surface epithelium and basement
membrane abnormalities.
Villous atrophy
Villous atrophy is present in all patients but is variable in
severity. Repeated biopsies are required.
Epithelium
In the typical form, abnormalities are localized mainly in
the epithelium and include disorganization of surface
enterocytes with focal crowding, resembling tufts (Figure
1). These characteristic "tufts" of extruding epithelium,
first described by Reifen et al. [3], are seen towards the vil-
lous tip and may affect up to 70% of villi.
Colonic disease
Tufts are not limited to the small intestine and also
involve the colonic mucosa [4].
Specific features
Focal enterocyte crowding can also be observed in the
crypt epithelium and, in addition, crypts often have an
abnormal aspect: they are dilated with features of pseudo
cysts and abnormal regeneration with branching (Figure
2) [4]. A study of biopsy specimens demonstrated that the
deposition of laminin and heparan sulfate proteoglycanOrphanet Journal of Rare Diseases 2007, 2:20 http://www.OJRD.com/content/2/1/20
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(HSPG) in the basement membrane was abnormal in
patients with IED, compared to that from patients with
celiac disease or autoimmune enteropathy [4]. Relative to
the controls, there was faint and irregular laminin deposi-
tion at the epithelial lamina propria interface and the
HSPG appeared large and lamellar, suggesting that abnor-
mal development of basement membrane was at the ori-
gin of the epithelial abnormalities (Figure 3a–b–c). In
addition, we observed an increased immunohistochemi-
cal expression of desmoglein in IED patients (Figure 4)
and ultrastructural changes in the desmosomes, which
were increased in length and number [5] (Figure 5a–b–c–
d).
Differential diagnosis
Neonatal early-onset severe diarrhea may lead to suspect
ions transport defects. However, congenital chloride
diarrhea (CLD) or congenital sodium diarrhea (CSD) can
be easily distinguished from the absence of hydramnios
and by blood and stool electrolytes assessment [9-11].
CLD is a rare autosomal recessive disorder of intestinal Cl/
HCO3 exchange caused by mutations in the SLC26A3
gene and characterized by persistent Cl rich diarrhea from
birth [9,10]. Patients with CLD present with lifetime
watery diarrhea with a high Cl content and low pH, caus-
ing dehydration and hypochloremic metabolic alkalosis.
Chloride is low in urine and very high in stools (Chloride
> 150 mmol/L > Sodium).
CSD is caused by defective sodium/proton exchange with
only few sporadic cases reported [11]. The genetics of the
disease have not yet been established. Patients with CSD
have acidosis and hyponatremia, and stools with high
concentrations of HCO3 and sodium (150 mmol/L).
Glucose-galactose malabsorption (GGM) is an autosomal
recessive disease that presents in newborn infants as a life-
threatening diarrhea [12]. The diarrhea ceases within 1 h
of removing the oral intake of lactose, glucose, and galac-
tose, but promptly returns with the introduction of one or
more of the offending sugars into the diet.
IED should be suspected in neonates with early-onset
intractable diarrhea persisting at bowel rest. According to
the early onset of diarrhea, MVA can be suspected. MVA is
a congenital disorder of the intestinal epithelial cells that
presents with persistent life-threatening watery diarrhea
and is characterized by morphological enterocyte abnor-
malities [13]. MVID manifests either in the first days of
life (early-onset form) or in the first two months of life
(late-onset form). MVID is a very rare disorder of
unknown origin, probably transmitted as an autosomal
recessive trait. Light microscopy shows accumulation of
PAS-positive granules at the apical pole of immature ente-
rocytes, together with atrophic band indicating microvil-
lus atrophy and, in parallel, an intracellular PAS or CD10
positive line. Ultrastructural analyses reveal a partial to
total atrophy of microvilli on mature enterocytes with api-
Intestinal epithelial dysplasia Figure 2
Intestinal epithelial dysplasia. Partial villous atrophy with 
crypt hyperplasia and/or pseudocystic crypt appearance, 
branching pictures and disorganization of surface epithelium.
Typical disorganization of surface enterocytes with focal  crowding forming tuft Figure 1
Typical disorganization of surface enterocytes with focal 
crowding forming tuft.Orphanet Journal of Rare Diseases 2007, 2:20 http://www.OJRD.com/content/2/1/20
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cal accumulation of numerous secretory granules in
immature enterocytes.
Sometimes, histopathological presentation of IED does
not show evidence of tufts. Diagnosis can be made by per-
forming repeated intestinal biopsies. Indeed, biopsies
change from being near-normal in early life (showing
only signs of non specific villous atrophy, with or without
monocellular cell infiltration of the lamina propria) to
revealing the characteristic tufts. In addition, specific
abnormalities of basement membrane components
(integrins or desmosomes) in parts of mucosa are rare and
difficult to detect in the absence of tufts [5]. In patients
with neonatal diarrhea and villous atrophy in which MVA
has been ruled out, the evidence of a punctuated keratitis
is very relevant for the diagnosis of IED, since more than
60% of IED have this association. IED differs from the dis-
ease reported in a newborn presenting with pyloric
atresia, intractable diarrhea and severe dermatitis which
was thought to be related to a congenital deficiency of
α6β4 integrin [15].
Another difficulty is related to T-cell infiltration of the
lamina propria. This is especially problematic when the
tufts are missing and supports the hypothesis of an
immune-related enteropathy. In a mouse model of dys-
functional E-cadherin, this primary disorder of epithelial
permeability or integrity was responsible for secondary T-
cell mediated mucosal damage [16]. Murch et al.
described these types of lesions in infants with epithelial
dysplasia [17]. Despite the lack of evidence from clinical
studies, increased intestinal permeability with subsequent
antigen epithelial crossing might explain immune reac-
tion within the lamina propria. Finally, this inflammation
reaction with missing or hard-to-find tufts often leads to
treat the disease as an immune enteropathy. In our expe-
rience, several children have been referred with the diag-
nosis of autoimmune enteropathy unresponsive to
immunosuppressive treatment and severe iatrogenic
symptoms from long-term steroids treatment.
Etiopathogenesis
IED has been shown to be associated with an abnormal
basement membrane [3]. Basement membrane molecules
are involved in epithelial mesenchymal cell interactions,
which are instrumental in intestinal development and dif-
ferentiation [18-23]. Alterations suggestive of abnormal
cell-cell and cell-matrix interactions have been seen in
patients with IED without any evidence for abnormalities
in epithelial cell polarization and proliferation [4]. Alter-
ations included abnormal distribution of α2β1 integrin
adhesion molecules along the crypt-villous axis. The α2β1
integrin is involved in the interaction of epithelial cells
with various basement membrane components, such as
laminin and collagen. To date, the pathophysiological
mechanisms resulting in the increased immunohisto-
chemical expression of desmoglein and the ultrastructural
changes of the desmosomes are unclear [4]. Mice in which
the gene encoding the transcription factor Elf3 is dis-
rupted have morphologic features resembling epithelial
dysplasia in infants [24]. In this model, there is abnormal
morphogenesis of the villi, while progenitor crypt cells
appear normal. The enterocytes produce low levels of
transforming growth factor-beta type 2 receptor, which
induces the differentiation of immature intestinal epithe-
lia. Both the clinical studies and the findings in experi-
mental animal models should provide clues to the
pathogenesis of these epithelial abnormalities and to the
cause of the severity of this neonatal diarrhea. Tufts corre-
spond to nonapoptotic epithelial cells at the villous tips
that are no longer in contact with the basement mem-
Normal deposition of laminin in control (a) but very feint and  lamellar in IED (b) while heparan sulfate proteoglycan  (HSPG) is overexpressed in the basement membrane Figure 3
Normal deposition of laminin in control (a) but very feint and 
lamellar in IED (b) while heparan sulfate proteoglycan 
(HSPG) is overexpressed in the basement membrane.
Intestinal epithelial dysplasia Figure 4
Intestinal epithelial dysplasia. Increased expression of desmo-
glein staining of the tight junction in a patient with intestinal 
epithelial dysplasia.Orphanet Journal of Rare Diseases 2007, 2:20 http://www.OJRD.com/content/2/1/20
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brane. It can be speculated that a defect in normal entero-
cyte apoptosis at the end of their lifespan or altered cell-
cell interactions are responsible for this effect. The pri-
mary or secondary nature of the formation of tufts
remains to be determined.
Genetic counseling and antenatal diagnosis
The clear association between the occurrence of IDE and
the presence of parental consanguinity and/or affected
siblings strongly suggests a genetic origin of this disorder.
These features suggest an autosomal recessive transmis-
sion. Genetic counseling may be based on the very proba-
ble autosomal recessive mode of transmission. Since the
causative gene(s) have not been yet identified, prenatal
diagnosis is not possible.
Management and outcome
IDE may be life-threatening, since the massive diarrhea
leads to rapid dehydration and electrolyte imbalance,
with subsequent metabolic decompensation within a few
days after birth. Diarrhea persists at a lower level despite
bowel rest. Attempts at continuous enteral feeding (CEF)
with a protein hydrolysate or amino acids based formulas
worsen the diarrhea, and the newborns rapidly fail to
thrive and develop protein energy malnutrition. Unfortu-
nately, patients have been continued on long-term enteral
feeding (EF) without improvement of the diarrhea and
with progressive severe protein energy malnutrition. As
mentioned above, the same is true for patients treated
with immunosuppressive drugs (especially steroids) some
time associated with cyclosporine because of mucosal
inflammation. Finally, most of the time this neonatal
diarrhea, which resists all treatments, requires permanent
parenteral nutrition (PN). However, it seems that some
infants have a milder phenotype than others [25]. Infants
with partial intestinal function and a limited amount of
stool output require only partial long-term PN infusions
3–4 times per week. Nevertheless, careful monitoring
should be performed to avoid progressive growth retarda-
tion.
In most patients, the severity of the intestinal malabsorp-
tion and diarrhea make them totally dependent on daily
long-term PN, with a subsequent risk of complications.
IDE causes intestinal failure that is clearly irreversible in
most patients. Liver disease may develop with subsequent
end-stage liver cirrhosis in patients with intestinal failure
as a consequence of both underlying digestive disease and
unadapted PN. Management of patients with intestinal
failure requires an early recognition of the condition and
analysis of the risk of irreversibility. Thus, in some cases
IED is an indication for intestinal transplantation [26-29]
and timing of referral for intestinal transplantation is cru-
cial.
The criteria for transplantation have been published in the
position paper of the American Society of Transplantation
[30] and continue to be debated, especially regarding vas-
cular thrombosis and sepsis. They are more guidelines
than formal recommendations and must be balanced
with the risks of intestinal transplantation. For instance,
in our practice only repeated life-threatening sepsis, espe-
cially when complicated with extensive thrombosis, may
be a criterion for transplantation. The poor quality of life
might serve as indication for intestinal transplantation
(ITx), although usual criteria including progressive liver
disease, the loss of vascular access, and recurring life-
threatening sepsis have not developed. In any case, par-
ents must be extensively informed about the risks of the
procedure and about the reasons of any decision [31].
Patients with irreversible intestinal failure and end-stage
liver disease (liver cirrhosis) are candidates for a life-sav-
ing procedure such as combined liver-small bowel trans-
Different pictures showing ultrastructural changes in the  desmosomes, which are increased in length and number Figure 5
Different pictures showing ultrastructural changes in the 
desmosomes, which are increased in length and number.Orphanet Journal of Rare Diseases 2007, 2:20 http://www.OJRD.com/content/2/1/20
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plantation (LITx). Patients with severe hepatic fibrosis are
more difficult to manage [31]. Repeated liver biopsies
within 6 to 12 months and careful assessment for portal
hypertension are necessary. In addition, it is difficult to
assess the amount of functional liver tissue necessary to
withstand the insult of portal diversion during the trans-
plantation procedure. Children with severe advanced and
progressive hepatic fibrosis are usually listed for LITx.
However, some PN-dependent patients with advanced
liver dysfunction may experience functional and bio-
chemical liver recovery.
In any case, when long-term PN is effective and well toler-
ated, it can be used for a prolonged period of time without
intestinal transplantation. The long-term prognosis is var-
iable. In general, management should be based on a
multidisciplinary approach in centers involving pediatric
gastroenterology, parenteral nutrition expertise, home
parenteral nutrition program, and liver intestinal trans-
plantation program.
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